XNIF:LSE:LSE-Xtrackers Nifty 50 Swap UCITS ETF 1C (GBX)

ETF | Others |

Last Closing

USD 20819.5

Change

+66.50 (+0.32)%

Market Cap

USD 0.25B

Volume

3.77K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+6.94 (+5.00%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.05 (+0.27%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.30%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.65 (-1.03%)

USD 266.08B
0QZO:LSE 0QZO

+0.30 (+0.28%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.05 (+0.18%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+4.82 (+2.90%)

USD 202.26B
0R24:LSE Intel Corp.

-0.64 (-2.93%)

USD 196.14B

ETFs Containing XNIF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.39% 8% B- 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.39% 8% B- 21% F
Trailing 12 Months  
Capital Gain 6.27% 37% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.27% 34% F 45% F
Trailing 5 Years  
Capital Gain 61.74% 75% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.74% 73% C 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 17.51% 83% B 82% B
Dividend Return 17.51% 82% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.14% 50% F 68% D+
Risk Adjusted Return 123.82% 98% N/A 99% N/A
Market Capitalization 0.25B 63% D 36% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike